K. B. MATHUR

597 total citations
47 papers, 431 citations indexed

About

K. B. MATHUR is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, K. B. MATHUR has authored 47 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 16 papers in Cellular and Molecular Neuroscience and 10 papers in Organic Chemistry. Recurrent topics in K. B. MATHUR's work include Neuropeptides and Animal Physiology (16 papers), Chemical Synthesis and Analysis (11 papers) and Receptor Mechanisms and Signaling (9 papers). K. B. MATHUR is often cited by papers focused on Neuropeptides and Animal Physiology (16 papers), Chemical Synthesis and Analysis (11 papers) and Receptor Mechanisms and Signaling (9 papers). K. B. MATHUR collaborates with scholars based in India and United States. K. B. MATHUR's co-authors include W. Haq, Vijay K. Singh, Tahira Naqvi, D. Balasubramanian, Shyam S. Agarwal, Bijoy Kundu, M.M. Dhar, S. S. Agarwal, Satyendra Kumar Garg and D. N. Tewari and has published in prestigious journals such as Journal of the American Chemical Society, FEBS Letters and Cellular and Molecular Life Sciences.

In The Last Decade

K. B. MATHUR

45 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. B. MATHUR India 13 227 141 62 58 38 47 431
Leonard S. Jacob United States 8 398 1.8× 111 0.8× 114 1.8× 47 0.8× 19 0.5× 15 673
Susumu Kurioka Japan 10 276 1.2× 65 0.5× 40 0.6× 12 0.2× 20 0.5× 22 523
Norman W. Thomas United Kingdom 14 127 0.6× 45 0.3× 87 1.4× 31 0.5× 19 0.5× 20 501
Caroline Morris United Kingdom 11 254 1.1× 53 0.4× 25 0.4× 63 1.1× 23 0.6× 15 482
Tomomi Kobayashi Japan 14 209 0.9× 44 0.3× 24 0.4× 24 0.4× 105 2.8× 40 520
M. Derrien France 10 338 1.5× 33 0.2× 111 1.8× 140 2.4× 19 0.5× 10 698
Saki Itonori Japan 14 345 1.5× 73 0.5× 96 1.5× 133 2.3× 78 2.1× 44 612
Radha Rangarajan United States 13 194 0.9× 150 1.1× 62 1.0× 30 0.5× 108 2.8× 19 489
Albert Tseng Australia 9 381 1.7× 151 1.1× 16 0.3× 15 0.3× 9 0.2× 22 561
Ernesto González Sweden 17 476 2.1× 106 0.8× 46 0.7× 15 0.3× 8 0.2× 27 738

Countries citing papers authored by K. B. MATHUR

Since Specialization
Citations

This map shows the geographic impact of K. B. MATHUR's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. B. MATHUR with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. B. MATHUR more than expected).

Fields of papers citing papers by K. B. MATHUR

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. B. MATHUR. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. B. MATHUR. The network helps show where K. B. MATHUR may publish in the future.

Co-authorship network of co-authors of K. B. MATHUR

This figure shows the co-authorship network connecting the top 25 collaborators of K. B. MATHUR. A scholar is included among the top collaborators of K. B. MATHUR based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. B. MATHUR. K. B. MATHUR is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Vijay K., et al.. (1999). δ-Opioid Receptor Antagonist Inhibits Immunomodulation by Met-Enkephalin Analogs. NeuroImmunoModulation. 6(5). 355–360. 12 indexed citations
2.
Singh, Vijay K., et al.. (1998). Immunomodulating activity of analogs of noninflammatory fragment 163–171 of human interleukin-1β. Immunopharmacology. 38(3). 237–245. 7 indexed citations
3.
Naqvi, Tahira, W. Haq, & K. B. MATHUR. (1998). Structure–activity relationship studies of dynorphin A and related peptides. Peptides. 19(7). 1277–1292. 37 indexed citations
4.
Singh, Vijay K., et al.. (1998). Thymopentin and splenopentin as immunomodulators. Immunologic Research. 17(3). 345–368. 49 indexed citations
5.
Naqvi, Tahira, Ram Raghubir, W. Haq, et al.. (1998). Synthesis and opioid activity of novel tetrapeptides analogous to sequence (1–4) of dermorphin. Neuropeptides. 32(4). 333–338. 1 indexed citations
6.
Singh, Vijay K., et al.. (1997). Stimulation of IL-2 production and CD2R expression by splenopentin analogs. International Journal of Immunopharmacology. 19(6). 341–345. 4 indexed citations
7.
Singh, Vijay K., et al.. (1997). Molecular Biology of Opioid Receptors: Recent Advances. NeuroImmunoModulation. 4(5-6). 285–297. 34 indexed citations
8.
Singh, Vijay K., et al.. (1997). Immunomodulation by two potent analogs of met-enkephalin. Immunopharmacology. 35(3). 213–220. 13 indexed citations
9.
Carlton, James E., Shahnawaz Khan, W. Haq, et al.. (1995). Attenuation of alcohol-induced hypothermia by cyclo (His-Pro) and its analogs. Neuropeptides. 28(6). 351–355. 2 indexed citations
10.
Nath, Chandan, et al.. (1995). Novel met-enkephalin analogue: a potent systemic mu agonist antinociceptive agent. Pharmacological Research. 31(5). 269–273. 3 indexed citations
11.
Pal, Rishi, et al.. (1995). Leishmania donovani in hamsters: Stimulation of non-specific resistance by novel lipopeptides and their effect in antileishmanial therapy. Cellular and Molecular Life Sciences. 51(7). 725–730. 6 indexed citations
12.
Fatma, Nigar, K. B. MATHUR, & R. K. Chatterjee. (1994). Chemotherapy of experimental filariasis: Enhancement of activity profile of ivermectin with immunomodulators. Acta Tropica. 57(1). 55–67. 10 indexed citations
13.
Haq, W., S. B. Katti, K. B. MATHUR, et al.. (1993). Enkephalin Antisense Peptides: Design, Synthesis, and Biological Activity. Pharmaceutical Research. 10(5). 660–661. 5 indexed citations
14.
Rastogi, Anil K., et al.. (1993). Augmentation of human natural killer cells by splenopentin analogs. FEBS Letters. 317(1-2). 93–95. 11 indexed citations
15.
Puri, A., W. Haq, P. Y. Guru, et al.. (1993). Inmjnostimjlant Activity of A Novel Lipopeptide and Its Protective Action Against Leishmnia Donovani. Immunopharmacology and Immunotoxicology. 15(5). 539–556. 9 indexed citations
16.
Murthy, P.K., et al.. (1992). Brugia malayi in Mastomys natalensis : Effect of Immunostimulators on Establishment and Course of Infection. Nagasaki University's Academic Output SITE (Nagasaki University). 34(2). 63–69. 3 indexed citations
17.
Pal, Rishi, et al.. (1991). Leishmania donovani in hamsters: Stimulation of non-specific resistance by some novel glycopeptides and impact on therapeutic efficacy. Cellular and Molecular Life Sciences. 47(5). 486–490. 14 indexed citations
18.
Rastogi, Anil K., et al.. (1989). Effect of some novel synthetic analogues of CCK-4 on insulin and glucagon secretion. Acta Diabetologica. 26(3). 203–209. 1 indexed citations
19.
Kant, Ravi, Kailash Chandra, B. M. Gupta, et al.. (1977). A study of anti-semliki forest virus activity of poly N epsilon-(2-aryl-2-thiazoline-4-carbonyl-L-lysines) in mice.. PubMed. 65(3). 314–9. 1 indexed citations
20.
MATHUR, K. B. & D. N. Tewari. (1968). The Swedish National Forest Inventory. Indian Forester. 94(7). 513–520. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026